All questions
Safety: Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in human papillomavirus vaccination 8 questions · 1 source
Safety questions that apply to every indication of Gardasil 9 are on Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications: Safety .
Side effects What are the most common side effects of Gardasil 9? “The most common (≥10%) local and systemic adverse reactions
reported:
•
In girls and women 16 through 26 years of age: injection-site pain
(89.9%), injection-site swelling (40.0%), injection-site erythema
(34.0%) and headache (14.6%). (6.1)
•
In girls 9 through 15 years of age: injection-site pain (89.3%),
injection-site swelling (47.8%), injection-site erythema (34.1%) and
headache (11.4%). (6.1)
•
In women 27 through 45 years of age: injection-site pain (82.8%),
injection-site swelling (23.3%), injection-site erythema (16.9%),
and headache (13.6%) (6.1)
•
In boys and men 16 through 26 years of age: injection-site pain
(63.4%), injection-site swelling (20.2%) and injection-site erythema
(20.7%). (6.1)
•
In boys 9 through 15 years of age: injection-site pain (71.5%),
injection-site
swelling
(26.9%),
and
injection-site
erythema
(24.9%). (6.1)” (opens the source at this quote in a new tab) Copy Flag
Does Gardasil 9 cause more injection-site reactions than Gardasil? How often did headache, fever, or nausea occur after Gardasil 9? How common were serious side effects with Gardasil 9 in clinical trials? Which postmarketing side effects were reported for Gardasil, the predecessor vaccine? Applies to GARDASIL (quadrivalent predecessor vaccine, HPV Types 6, 11, 16, and 18); the Gardasil 9 label states that its efficacy and effectiveness are relevant to Gardasil 9
“The following postmarketing adverse experiences have been spontaneously reported for GARDASIL:
Blood and lymphatic system disorders: Autoimmune hemolytic anemia, idiopathic thrombocytopenic
purpura, lymphadenopathy.
Respiratory, thoracic and mediastinal disorders: Pulmonary embolus.
Gastrointestinal disorders: Nausea, pancreatitis, vomiting.
General disorders and administration site conditions: Asthenia, chills, death, fatigue, injection-site
nodule, malaise.
Immune
system
disorders:
Autoimmune
diseases,
hypersensitivity
reactions
including
anaphylactic/anaphylactoid reactions, bronchospasm, and urticaria.
Musculoskeletal and connective tissue disorders: Arthralgia, myalgia.
Nervous system disorders: Acute disseminated encephalomyelitis, dizziness, Guillain-Barré syndrome,
headache, motor neuron disease, paralysis, seizures, syncope (including syncope associated with tonic-
clonic movements and other seizure-like activity) sometimes resulting in falling with injury, transverse
myelitis.
Infections and infestations: Cellulitis.
Vascular disorders: Deep venous thrombosis.” (opens the source at this quote in a new tab) Copy Flag
Safety Were any deaths linked to Gardasil 9 in clinical trials? How often were autoimmune conditions reported after Gardasil 9 in trials? How was Gardasil 9 safety established in men 27 to 45? Applies to Men 27 through 45 years of age